<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Roerig Division of Pfizer Inc., et al.; Withdrawal of Approval of 10 Abbreviated New Drug Applications; Correction</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Roerig Division of Pfizer Inc., et al.; Withdrawal of Approval of 10 Abbreviated New Drug Applications; Correction</h1>
    <p class="timestamp">Published: 2020-09-29 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register on July 21, 2020. The document announced the withdrawal of approval of 10 abbreviated new drug applications (ANDAs) from multiple applicants, withdrawn as of August 20, 2020. The document indicated that FDA was withdrawing approval of the following two ANDAs after receiving a withdrawal request from Kadmon Pharmaceuticals, LLC., 119 Commonwealth Dr., Warrendale, PA 15086: ANDA 076203, Ribavirin Ca...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2020-21456</p>
    <p><strong>Publication Date:</strong> 2020-09-29</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2020/09/29/2020-21456/roerig-division-of-pfizer-inc-et-al-withdrawal-of-approval-of-10-abbreviated-new-drug-applications">https://www.federalregister.gov/documents/2020/09/29/2020-21456/roerig-division-of-pfizer-inc-et-al-withdrawal-of-approval-of-10-abbreviated-new-drug-applications</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2020-21456</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
